ESC CVD Risk Calculation
Medical
100K+ installs
Advertisement
- CategoryMedical
- PlatformAndroid
- DeveloperEuropean Society of Cardiology
- In-app PurchasesNo
- Installs100K+
- Updated2025-05-16
- Size18 M
- Version1.6
Advertisement
Editor's Review
ESC CVD Risk Calculation is a medical app from European Society of Cardiology. In the developer's own words: "Individual cardiovascular risk assessment for healthcare professionals." With 100K+ installs on Google Play, it holds an average rating of 4.3 from 580 user ratings. The latest version (1.6) was released on 2025-05-16. Good to know: it needs about 18 MB of storage.
How To Use?
Install ESC CVD Risk Calculation from Google Play and open it
Allow only the permissions you are comfortable with
Complete the setup or sign-in steps if the app asks for them
Explore the main menu to find the key features
Keep the app updated for new features and fixes
Google Play
Description
The ESC CVD Risk Calculation App is designed for healthcare professionals. It provides calculators assessing individual cardiovascular risk. It includes calculators for primary and secondary prevention in various populations:
SCORE2
SCORE2-OP
SCORE2-Diabetes
ASCVD
SMART
SMART-REACH*
DIAL*
LIFE-CVD*
* Available online on U-Prevent (Internet connection required)
The ESC CVD Risk Calculation App is available in English. It provides guidance to the most adapted calculator for your patient, and provides an estimation of cardiovascular risk. Of note, patient data are not stored in the App.
This application is only for informative use and is not intended to provide therapeutic support or diagnosis assistance.
This Application is powered by the European Society of Cardiology (ESC), based upon the source codes of the U-Prevent webtool, a concept developed by University Medical Center Utrecht, redesigned and owned by ORTEC.
The SCORE2, SCORE2-OP and SCORE2-Diabetes calculators were developed in collaboration with the ESC Cardiovascular Risk Collaboration unit.
The Application has recently been updated in the framework of the EAPC IMPLEMENT Programme (2023) which was supported by Novo Nordisk in the form of an educational grant. The sponsor did not have any involvement or influence on the features nor on the scientific contents within the Application.
Screenshots
4.3
Featured App